Skip to end of metadata
Go to start of metadata

The Langenau Laboratory at the Massachusetts General Hospital, Boston is recruiting a research fellow to study the role of a novel HMG box protein in regulating DNA repair and leukemogenesis.  Research will focus on using cutting edge proteomics, biochemistry, cell biological assays, and zebrafish animal modeling.

Dr. Langenau’s research group has become a pioneer in the field pediatric cancer research.  The laboratories interests are best summarized in the following manuscripts (Moore et al., JEM, 2016; Tang et al., Nature Communications, 2016; Blackburn et al., Cancer Cell 2014; Tang et al., Nature Methods, 2014; Chen et al., PNAS 2014; Ignatius et al., Cancer Cell 2012).  Additional information about the laboratory is available at

Applicants with advanced skills in zebrafish genetics, DNA repair, proteomics, biochemistry, and cell biological assays (including ChIP seq) are highly desired. 

Candidates must have PhD and/or MD, have made significant scientific contributions through publication of high impact papers, and be enthusiastic about science.

A curriculum vitae, list of publications, and three references should be provided as a single PDF by December 20th, 2016 to:


David Langenau

Molecular Pathology Unit

Massachusetts General Hospital

149 Thirteenth Street, Room 6133

Charlestown, MA 02129


The Langenau laboratory research focus is to uncover the mechanisms driving progression and relapse in pediatric tumors. Using novel, transgenic zebrafish models of pediatric sarcoma and leukemia that mimic human malignancy, we have undertaken studies to discover novel therapies by addition of drugs to the water and imaging tumor growth in live zebrafish.  Moreover, we have utilized detailed imaging studies to visualize tumor cells in live animals and assess how cellular heterogeneity drives continued tumor growth.  Capitalizing on insights gained from our zebrafish models of cancer, we are now extending our findings to human T-cell acute lymphoblastic leukemia and rhabdomyosarcoma.

Massachusetts General Hospital, a leading medical center located in the heart of Boston, is consistently ranked among the top hospitals in America. The original and largest teaching hospital of Harvard Medical School, Mass General conducts the largest hospital-based research program in the United States and is the top recipient of research funding from the National Institutes of Health (NIH). Mass General has long been a leader in successfully bridging innovative science with state-of-the-art clinical medicine and topped the Nature Index list of health care organizations for publishing more articles in high-impact journals than any other hospital in America from February 2015 to January 2016.

  • No labels